{{Rsnum
|rsid=498793
|Gene=FADS2
|Chromosome=11
|position=61857233
|Orientation=minus
|GMAF=0.3127
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FADS2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 48.7 | 36.3
| HCB | 0.7 | 16.9 | 82.4
| JPT | 0.0 | 16.1 | 83.9
| YRI | 15.0 | 40.1 | 44.9
| ASW | 10.5 | 52.6 | 36.8
| CHB | 0.7 | 16.9 | 82.4
| CHD | 0.9 | 16.7 | 82.4
| GIH | 11.9 | 48.5 | 39.6
| LWK | 12.8 | 50.5 | 36.7
| MEX | 19.3 | 28.1 | 52.6
| MKK | 18.1 | 51.0 | 31.0
| TSI | 19.6 | 50.0 | 30.4
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs498793
|Name_s=
|Gene_s=FADS2
|Feature=
|Evidence=PubMed ID:16893529
|Annotation=This variant in FADS2 gene was significant associated with attention-deficit/hyperactivity disorder.
|Drugs=
|Drug Classes=
|Diseases=Attention Deficit Disorder with Hyperactivity
|Curation Level=Curated
|PharmGKB Accession ID=PA162360176
}}

{{PMID Auto
|PMID=20565855
|Title=Genetic variation in lipid desaturases and its impact on the development of human disease.
|OA=1
}}

{{PMID Auto
|PMID=21414826
|Title=Polymorphisms in FADS1 and FADS2 alter desaturase activity in young Caucasian and Asian adults.
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs498793
|overall_frequency_n=78
|overall_frequency_d=120
|overall_frequency=0.65
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=62
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=22877655
|Title=Umbilical cord PUFA are determined by maternal and child fatty acid desaturase (FADS) genetic variants in the Avon Longitudinal Study of Parents and Children (ALSPAC)
|OA=1
}}

{{PMID Auto
|PMID=23285256
|Title=Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}